4//SEC Filing
VAN VOORHEES SETH 4
Accession 0001415889-22-012652
CIK 0001719406other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 7:09 AM ET
Size
5.1 KB
Accession
0001415889-22-012652
Insider Transaction Report
Form 4
VAN VOORHEES SETH
Chief Financial Officer
Transactions
- Purchase
Common Stock, par value $0.001 per share
2022-12-16$1.10/sh+30,000$33,000→ 46,337 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.11. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
Documents
Issuer
NRX Pharmaceuticals, Inc.
CIK 0001719406
Entity typeother
Related Parties
1- filerCIK 0001284934
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 7:09 AM ET
- Size
- 5.1 KB